{"entity":{"type":"insider","cik":"0002010692","url":"/insider/0002010692","json_url":"/insider/0002010692.json","name":"Panacea Innovation Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2025-07-21","last":"2026-05-11","span_basis":"filed_date"},"name_variants":[{"name":"Panacea Innovation Ltd","source":"filing","n_filings":4,"first_seen":"2025-07-21","last_seen":"2026-05-11"}],"transactions":[{"id":5959451,"accession":"0001193125-26-217380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-217380","line_url":"/filing/0001193125-26-217380#line-1","is_derivative":false,"issuer_cik":"0001573160","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001573160","owner_cik":null,"owner_name":"Huang James; Panacea Innovation Ltd","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":313446.0,"shares_display":"313,446","price_per_share":10.0975,"price_display":"10.10","price_state":"stated","total_value":3165020.985,"total_display":"3,165,020.98","shares_owned_after":1011000.0,"shares_owned_after_display":"1,011,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-11","scope":"insider"},{"id":5893621,"accession":"0001193125-26-013358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-013358","line_url":"/filing/0001193125-26-013358#line-1","is_derivative":false,"issuer_cik":"0001573160","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001573160","owner_cik":null,"owner_name":"Huang James; Panacea Innovation Ltd","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80554.0,"shares_display":"80,554","price_per_share":6.0707,"price_display":"6.07","price_state":"stated","total_value":489019.1678,"total_display":"489,019.17","shares_owned_after":1324446.0,"shares_owned_after_display":"1,324,446","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":4912759,"accession":"0000950170-25-110310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-110310","line_url":"/filing/0000950170-25-110310#line-1","is_derivative":false,"issuer_cik":"0001573160","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001573160","owner_cik":null,"owner_name":"Huang James; Panacea Innovation Ltd","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":12.1895,"price_display":"12.19","price_state":"stated","total_value":670422.5,"total_display":"670,422.50","shares_owned_after":1405000.0,"shares_owned_after_display":"1,405,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-19","scope":"insider"},{"id":4342067,"accession":"0000950170-25-097087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-097087","line_url":"/filing/0000950170-25-097087#line-1","is_derivative":false,"issuer_cik":"0001573160","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001573160","owner_cik":null,"owner_name":"Huang James; Panacea Innovation Ltd","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19335.0,"shares_display":"19,335","price_per_share":9.6391,"price_display":"9.64","price_state":"stated","total_value":186371.9985,"total_display":"186,372.00","shares_owned_after":1350000.0,"shares_owned_after_display":"1,350,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Ten percent owner","n_filings":4,"first_seen":"2025-07-21","last_seen":"2026-05-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002010692","retrieved_at":"2026-08-21T17:11:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}